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It is known Ih.t PKC is differently expressed i~ brain and the peripheral nervous ~y~tem and is involved in ¢dlular differentia|iol'D. We have ~nal:cxcd 
9 human neuronnl.dcrived cre~t.¢dl Iinc~ r~r PKC.:t mRNA. Seven our of nine expr©~ted 9,0 kb and 4,0 kb PKC.= mRNAI, but three had hil!h 
level or 9,0 kb tran~criptiol'4. The dill'ercnl expression of the Iwo mcssenlNr RN^~t m:~y result from aitcrnmive ~pllcinl; and ~ different d¢llree or 
cell maturation, The mtm~ cell linex were ~;tudled rot MYCN eerie expr~:~ion, A poslihlc relalion I~twecn the lw~ l~e~¢s i discussed, One cell 
line expressinB htBh levds of both PKC, z mRNA win'. |re,ted wi|h 1O "~ M relinoic acid (RAI. Tl~e expression of bolh messenger RN^~ wn~ sup. 
pressed when the cells achieved ~ morpholotlieal differentiation a d showed neuritc.lik~ processes. A dcere;~ of PKC.'. Senc expre~;sion was a~so. 
elated to down ret~ulation of MYCN mRNA, These prelimlnary results suligest hat PKC suppression ofPKC-:t n',RNA i~ associated with reversion 
oP the mali~nnnt phen~lyi~, 
Neuromd irl~rentiadon; Human neuroblastorn.; PKC-:c; Gone expression; Re1 inoic acid 
1. INTRODUCTION 
Protein kinase C (PKC), a phospho l ip id ,  and 
calcium-dependent kinase, is the natural cellular recep- 
tor for the phorbol ester tumor promoter (TPA). PKC 
is involved in many functions including control of cell 
proliferation [1], There is also evidence that PKC is in- 
volved in transformation caused by oncogenes in vitro 
[3-5] and persistent activation of PKC has been 
associated with a transformed pl~enotype [6]. The PKC- 
c¢ gene is coded by multifamily genes ince at least 3 dif- 
ferent genes were isolated from bovine, rat, and human 
eDNA libraries [7-9]. Different PI~.C.~ mRNAs have 
been demonstrated in rat and in human cells and prob- 
ably the related protein have different functions 
[7,10,11], In the rat at least wo different mRNAs of 9.0 
and 4.0 kb have been identified and their different ex- 
presmon in various anatomical regions suggest distinct 
functions [10]. Northern blot analysis shows PKC.~ 
mRNA in the brain and in the spinal cord of the rat and 
in the brain but not in the spinal cord of the monkey 
(reviewed in [1]). 
We have investigated the PKC.c~ gene expression i  9 
human euroblastoma cell lines; a neuroblastoma being 
a tumor derived from the neuroectodermal tissue which 
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very often expresses MYCN oncogen¢. Two PKC-ot 
mRNAs, respectively of 9,0 and 4.0 kb were differently 
expressed in these tumor cells. PKC-e expression was 
found in 7 out of 9 ceil lines. To investigate if the PKC- 
e¢ expression is maintained uring cell differentiation 
we have also studied the expression of  PKC-(~ in SK-N- 
BE(2)C cells treated with retinoic acid (RA). In fact, it 
is known that neuroblastorna ceils can be it'tduced to 
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Fig, 1 Expression of PKC-o~ and MYCN genes in human 
neuroblastoma cell lines. 
Published by Elsevier Science Publishers B.V. 221 
V~lum¢ 2SO, humor  2 
A 
, ~,lard~ I~ I  I~BS L~Tri~R~ 
Fig, 2, Morphological change and neuritis outgr0W[h in SK-N.BE(2)C cells treated with 10" 5 M RA: A, Control; B, RA-treated, Magnif catiol~s ..
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differentiate In vhm emploFInl~ ~e,~eral chemical or 
natural a~enl~ |12.. 14]. Oar re,tails .~how that PKC.r~. i~ 
not expressed in all neurobla~toma cell~ ~ul==e'~tlnl~ a 
different molecular pattern of PKC-~r transcription In 
thi~ tumor, Moreover, PKC'-tt mRNA is inhibited dur. 
in~ neuroblastoma cell differentiation and it appears 
that PKC-,~ i~ involved in neural cell differentiation, 
2, MATERIALS AND METHODS 
[,AN.I, LAI'~4, (pr¢~ided b> Dr R, S¢,c1~¢r. (AL IMR.~, IMR=)2. 
SK-N-SH. SK.N.lt~(.~)(: tpr~',td,cd by Dr V. ~*i~*~¢,arolt~ and J. 
I~iedler. NY}. CII-ME.N. GI.CA,N, ~md ¢iI.LI-N II;~-I'~l wlt lia~ 
wer~, ulllitlrg'd ill RPMI 164tl m~dh|ltt (~¢di~o. S~;otl~nd. URI ~,t~p, 
plemenled with I.~w~ f¢lal calf t¢¢um (F¢~'S} tEiib<o, S¢olland, UKI. 
2a/= penidlltn.~lreptonty¢in tFlow Luboralori¢~. Milant~, IlalXt, I% 
i~lulamin~ tGib¢o), SK.N.IIEt2)¢,: (3a¢10 '~ ,¢¢ll~fla~k I'/0 ,;.'c', 
B¢~|o~t.Diekln~om NY) v, cr~ treated twice wilh 10 ~ ~ M RA tSit~ma. 
SI. l,mii~, MO) and 01~wP,.~d IhrOul~h a etantra~t-pha~¢ ml~:ro~¢OlU: 
undl the morpltolo¢ieal differemlad~n ~a~ adtievetl, The edl~ were 
my¢onla~m,t.fre¢ tMy¢opla~ma levi kit l)api. I-to,dtrln~r.Mannhehrt, 
W¢~t German,'I, 
2,2, RNA Northern hhJt unnl, vsts 
I~,NA~ were exlr'dgted from edl ~:ullure~ a~ pray|outlet tler<ribed 
1181, Briefly, 20 ml~ or total RNA ~,.t~, run int a 1.2% rori'tlaldeh~,~de 
a~.aro~e ~¢1 el¢¢lrophore~tx and transferred onlo nhro~;dlulo~e fiherr, 
(BRL, Belhe~d~l, USA}, Fillers tver¢ hybridized with [~.~"P]dC~P 
(]000 nlCJtm~l, Amersham, LIK) ~t'o RI frasm~nt labeled |ltlntttll 
PKC-¢¢ (provided by Dr J, Kno[ff, Genelk:s 111~1,) al 42"C wilh 500;0 
formamide, washed and exposed to Kod:lk S.Omat trim, The filter~ 
were st|bseq!.l¢l~tly boiled and hybrid|ted a~ain with l~x,J~PldCTP 
MYCN 2,0 E¢o RI rrailment repro plam'dd g, UCg.N.myc (NB-19.2I) 
provided b~,, Dr F, All (Columbia Universily, NY} .'rod al~ain with 
[=v.'~:P] dCTP 28S riboxomal RNA (rENAl probe and finally exp0sed 
at tl~e same condition~ dexeribed above, All probe~ were labded with 
[¢¢-r~'P]dC'TP using the random pri=r~ing leehnique [191 employ|n8 a 
Muhiprinte DNA labelin~d ,system tAmer,sham, UK). 
3. RESULTS 
EaT)ression of  PKC-c~ mRNA in human neuroblastooTa 
cell lines 
Different neuroblastoma cell lines were tested for ex. 
press|on of  PKC-~ mRNA.  The results o f  a represen- 
tative experiment are shown in Fig, 1.  Every cell line 
tested expressed a 9 kb and 4 kb PKC-u  transcript o a 
varmble degree, LAN-5 and SK-N-BE(2)C 
demonstrated the highest level o f  expression, in two cell 
lines (LAN-1 and SK-N.SH)  the 9 kb band was either 
negative or at the limit of  detection depending on the 
experiment. Interestingly, the cell lines could be divided 
into two categories on the bases o f  the relative expres- 
sion of  tile two mRNA species. In 4 o f  them (GI -ME-N,  
LAN- I ,  G I .CA-N ,  SK-N-SH) the 4 kb band was more 
intense than the 9 kb band; in the remaining 6 the 9 kb 
band was similar (GI-L I -N) or predominant .  These 
results demonstrated that neuroblastoma cell lines ex- 
Press PKC-c~ mRNA and differ in the relative expres- 
sion of  the two main transcripts. 
The same cell lines were tested for the expression o f  
MYCN,  The resalts shown tn Fij ,  l Indicate thai 
M¥CN was expressed in but 6 of the 9 ~:ell ines |esled, 
Amonl! the MYtqN.postt|ve eell~, LAN!  consistently 
expressed MYCN mRNA 10=~0 lime~ less than the 
other cell lines. It ts interestin~ that  stron ~ expression 
of  MYCN wa~ associated with the predominant expres. 
sion of the 9 kb PKC.¢~ mRNA while poor or noexpres. 
slon of  MYCN ~.ts found in the cell lines expressint! 
predominantly the 4 kb PKC.¢¢ mRNA. The same blot 
hybridized to n 28S rRNA probe confirmed that equal 
amounts  o f  total RNA were blotted, These result~ ~u~. 
lJest a correlat ion between 9 kb PKC- ,  mRNA and 
MYCN expression, 
The SK-N-BE(2)C cell line was selected for further 
studies on the expression o f  PKC.~ mRNA during the 
neuronal  differentiat ion induced by RA, RA  induces 
dif ferentiat ion o f  SK-N.BE(2)C cells as shown by the 
induct ion o f  neurite format ion (Fil~..2). A differen- 
t iated phenotype became evident a f te r  2 days of  ex- 
posure to RA and reaclied a maximum after 5 to 7 days 
depending on the experiment. The differentiat ion pro- 
cess was associated with a concomitant ¢lecrease in the 
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Fig, 3, Changes at 24, 48 and 72 h (from right to left ~ of the expression 
of PKC-c¢ and MYCN in SK-N-BE(2)C treated with RA. The 28S 
rRNA expression was used to check the amount of mRNAs loaded on 
the gel, 
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9 and 4 kb PgC.¢t mRNAs  were undetectable alter 2 
days of  exposure or  the cells to RA.  A decrease in 
MYCN,  but nee in PgC.c~ n lRNA expression was also 
observed in control  cul|ures when they reached con- 
fluence alter about 3 days of  culture, However. ar=er 
two days of  culture a clear decrease of  MYCN expres- 
sion in R A-treuted ceils relative ~o controls was evid¢nt, 
4. DISCUSSION 
Our studies on the expression of PKC.¢~ mRNA 
demonstrated a variable degree of  suppression of this 
gene among various neuroblastoma cell lines, perhaps 
reflecting the heterogeneity of these cells. The expres- 
sion of MYCN was also variable with 5 lines expressing 
high levels, one low level and 3 undetectable l vels o f  
MYCN mRNA, However, a comparison between 
MYCN and PgC-~ mRNA levels in the different cell 
lines indicated the.interesting association between high 
expression of MYCN mRNA and predominant expres- 
sion of  the 9 kb, relative to the 4 kb band of PgC.c~ 
mRNA,  There are indications that the two species of 
PKC-~x rnRNA may derive from alternative splicing 
and/or  processing of PKC-a  mRN:~ precursors and 
that both species code for a 76 kDa polypeptide 
recognized by anti .PKC antibodies. Our results maw in- 
dicate that different pathways of PKC.c~ mRNA are 
predominantly utilized by individual neuroblastoma 
lines, The fact that the pathway of maturation of PKC- 
o¢ mRNAto  the 4 kb species may also inhibit MYCN ex- 
pression is an interesting possibility that ~s presently 
under investigation. However, a more intensive analysis 
o f  other neuroblastoma cell lines is necessary to support 
the hypothesis of  a casual relationship between the two 
phenomena, 
A recent report indicates that PKC plays a key role in 
the control o f  neural cell differentiation. Inhibition of 
PKC by l-(5-isoquinolinylsulfonyl).2.methyl-piper. 
azine (H7) is associated with neurite outgrowth in 
murine neuro.2a cells and in human neuroblastoma 
cells [20,21]. Previous reports indicate that PKC is in. 
hibited by treatment with RA in transformed rat cell 
lines [22] and in mouse neuroblastoma cell lines [23], 
We employed RA treatment to induce neural differen. 
tiation of the SK-N-BE(2)C.72 h after continuous RA 
treatment he transcription of both PKC.u mRNAs 
were completely inhibited and MYCN mRNA was 
detectable at low levels. SK-N-BE(2)C cells changed 
dramatically their morphology, and neurite structures 
became evident like in the mature neuron with several 
interconnections, Thiele et al. [24] and our previous 
observation [25] indicated that the decrease of  M¥CN 
gene expression was not related to RA-induced growth 
arrest. Data reported here confirm that the down- 
regulation of MYCN e×pression was associated with the 
neurite formation and neural dif ferentiat ion, More- 
over. PKC-c~ gene expression is inhibited during 
neuronal differentiation. PKC-u mRNA decreases to 
undetectabl¢ levels durin~l the RA.induced diftcren. 
t iadon or  Nfi cells, We stl~gest hat down.m,~dulation 
or PKC.= gene expression is associated with the rever. 
sion of malignant neuroblast to a more mature 
neuronal. l ike phenotyp¢, 
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